These findings demonstrate that the IGF1-IGF1R signaling pathway exerts a dual function in ovarian cancer metastasis by enhancing cell survival through inhibition of anoikis and facilitating tumor dissemination via increased cellular motility. Here, IGF1 is linked to ovarian carcinoma.